PTCT FY 2023 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$6B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$938M+34.2% YoY

Gross Profit

$872M93.0% margin

Operating Income

-$440M-46.9% margin

Net Income

-$627M-66.8% margin

EPS (Diluted)

$-8.37

Cash Flow

Operating Cash Flow

-$158M

Free Cash Flow

-$279M

Stock-Based Comp.

$131M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$2.7B

Stockholders' Equity

-$819M

Cash & Equivalents

$594M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$938M	$699M	+34.2%
Gross Profit	$872M	$654M	+33.4%
Operating Income	-$440M	-$447M	+1.8%
Net Income	-$627M	-$559M	-12.1%